O. Mejjad

1.9k total citations
59 papers, 1.3k citations indexed

About

O. Mejjad is a scholar working on Rheumatology, Surgery and Hematology. According to data from OpenAlex, O. Mejjad has authored 59 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Rheumatology, 14 papers in Surgery and 11 papers in Hematology. Recurrent topics in O. Mejjad's work include Rheumatoid Arthritis Research and Therapies (19 papers), Systemic Lupus Erythematosus Research (12 papers) and Autoimmune and Inflammatory Disorders Research (9 papers). O. Mejjad is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (19 papers), Systemic Lupus Erythematosus Research (12 papers) and Autoimmune and Inflammatory Disorders Research (9 papers). O. Mejjad collaborates with scholars based in France, United States and Chile. O. Mejjad's co-authors include Xavier Le Loët, Olivier Vittecoq, A Daragon, Thierry Lequerré, Sophie Pouplin, Jean-François Ménard, François Tron, Pierre Quartier, M Michel and F.Z. Alaoui and has published in prestigious journals such as Spine, Annals of the Rheumatic Diseases and Osteoarthritis and Cartilage.

In The Last Decade

O. Mejjad

55 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Mejjad France 17 665 355 294 274 252 59 1.3k
Rosaria Talarico Italy 26 986 1.5× 232 0.7× 298 1.0× 210 0.8× 243 1.0× 108 2.0k
Adeline Ruyssen‐Witrand France 24 1.5k 2.3× 555 1.6× 567 1.9× 277 1.0× 198 0.8× 109 2.2k
Dilek Solmaz Türkiye 19 477 0.7× 183 0.5× 410 1.4× 170 0.6× 435 1.7× 113 1.3k
Éric Houvenagel France 20 622 0.9× 188 0.5× 227 0.8× 268 1.0× 68 0.3× 68 1.3k
F Fantini Italy 23 574 0.9× 767 2.2× 296 1.0× 297 1.1× 280 1.1× 69 1.6k
P Maddison United Kingdom 20 983 1.5× 147 0.4× 385 1.3× 167 0.6× 103 0.4× 38 1.6k
Ulf Müeller-Ladner Germany 13 627 0.9× 158 0.4× 215 0.7× 201 0.7× 203 0.8× 28 1.3k
C Job-Deslandre France 23 1.2k 1.8× 610 1.7× 297 1.0× 773 2.8× 365 1.4× 87 2.0k
Gregory F. Keenan United States 16 609 0.9× 358 1.0× 509 1.7× 508 1.9× 172 0.7× 27 1.8k
Hiroshi Kaneko Japan 22 580 0.9× 258 0.7× 264 0.9× 182 0.7× 150 0.6× 80 1.4k

Countries citing papers authored by O. Mejjad

Since Specialization
Citations

This map shows the geographic impact of O. Mejjad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Mejjad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Mejjad more than expected).

Fields of papers citing papers by O. Mejjad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Mejjad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Mejjad. The network helps show where O. Mejjad may publish in the future.

Co-authorship network of co-authors of O. Mejjad

This figure shows the co-authorship network connecting the top 25 collaborators of O. Mejjad. A scholar is included among the top collaborators of O. Mejjad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Mejjad. O. Mejjad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Daveau, Romain, I. Auquit-Auckbur, Patrice Fardellone, et al.. (2012). Synovium CD20 expression is a potential new predictor of bone erosion progression in very-early arthritis treated by sequential DMARDs monotherapy – A pilot study from the VErA cohort. Joint Bone Spine. 79(6). 574–580. 12 indexed citations
3.
Pergolizzi, Joseph V., Cayetano Alegre, David R. Blake, et al.. (2011). Current Considerations for the Treatment of Severe Chronic Pain: The Potential for Tapentadol. Pain Practice. 12(4). 290–306. 34 indexed citations
4.
Perrot, Serge, Rose‐Marie Javier, Marc Marty, et al.. (2008). Atteintes ostéoarticulaires induites par les traitements par anti-aromatases au cours du cancer du sein. 14(5). 271–275. 1 indexed citations
5.
Bacquet-Deschryver, Hélène, F. Jouen, Muriel Quillard, et al.. (2008). Impact of Three Anti-TNFα Biologics on Existing and Emergent Autoimmunity in Rheumatoid Arthritis and Spondylarthropathy Patients. Journal of Clinical Immunology. 28(5). 445–455. 35 indexed citations
6.
Lequerré, Thierry, Pierre Quartier, F.Z. Alaoui, et al.. (2007). Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Annals of the Rheumatic Diseases. 67(3). 302–308. 281 indexed citations
7.
Vittecoq, Olivier, et al.. (2007). Mevalonate kinase deficiency syndrome with structural damage responsive to anakinra. Lara D. Veeken. 46(12). 1860–1862. 20 indexed citations
8.
Clavel, Gaëlle, Natacha Bessis, Delphine Lemeiter, et al.. (2007). Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. Clinical Immunology. 124(2). 158–164. 73 indexed citations
9.
Thirion, Laurence, et al.. (2006). Vasculite avec ulcérations cutanées au cours de la polyarthrite rhumatoïde : traitement par anti TNFδ. Annales de Dermatologie et de Vénéréologie. 133(5). 453–455. 7 indexed citations
10.
Goëb, Vincent, Philippe Dieudé, Olivier Vittecoq, et al.. (2005). Association between the TNFRII 196R allele and diagnosis of rheumatoid arthritis. Arthritis Research & Therapy. 7(5). R1056–62. 21 indexed citations
11.
Mejjad, O., et al.. (2003). Foot orthotics decrease pain but do not improve gait in rheumatoid arthritis patients. Joint Bone Spine. 71(6). 542–545. 43 indexed citations
12.
Mejjad, O., et al.. (2001). A shock associated with adult-onset Still’s disease. Joint Bone Spine. 68(1). 76–78. 5 indexed citations
13.
Mejjad, O., Sophie Favre, F. Dujardin, et al.. (2000). Efficacy of etodolac on gait in hip osteoarthritis as assessed by Bessou's locometer: a randomized, crossover, double-blind study versus placebo. Osteoarthritis and Cartilage. 8(3). 230–235. 7 indexed citations
14.
Vittecoq, Olivier, O. Mejjad, P Mitrofanoff, et al.. (2000). Evolution of chronic recurrent multifocal osteitis toward spondylarthropathy over the long term. Arthritis & Rheumatism. 43(1). 109–119. 95 indexed citations
15.
Vittecoq, Olivier, et al.. (1998). Spinal Abscess and Spondylitis Due to Actinomycosis. Spine. 23(4). 487–490. 25 indexed citations
16.
Louvel, J, et al.. (1997). Computed tomography of sternoclavicular joint lesions in spondylarthropathies. Skeletal Radiology. 26(7). 419–423. 11 indexed citations
17.
Loët, Xavier Le, J.F. Ménard, O. Mejjad, et al.. (1996). Computed tomography of the normal sternoclavicular joint. Skeletal Radiology. 25(3). 237–241. 23 indexed citations
18.
Vittecoq, Olivier, O. Mejjad, K.H. Ly, et al.. (1996). Preliminary experience with low‐dose methotrexate in fibroblastic rheumatism. Arthritis & Rheumatism. 39(12). 2070–2073. 15 indexed citations
19.
Dujardin, F., et al.. (1995). [Intra and interindividual variations of pelvic mobility in normal adult walk].. PubMed. 81(7). 592–600. 10 indexed citations
20.
Mejjad, O., et al.. (1993). EXACERBATION OF SYSTEMIC LUPUS ERYTHEMATOSUS DURING HUMAN PARVOVIRUS B19 INFECTION. Lara D. Veeken. 32(2). 158–159. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosaria Talarico Breakdown of academic impact, for papers by Adeline Ruyssen‐Witrand Breakdown of academic impact, for papers by Dilek Solmaz Breakdown of academic impact, for papers by Éric Houvenagel Breakdown of academic impact, for papers by F Fantini Breakdown of academic impact, for papers by P Maddison Breakdown of academic impact, for papers by Ulf Müeller-Ladner Breakdown of academic impact, for papers by C Job-Deslandre Breakdown of academic impact, for papers by Gregory F. Keenan Breakdown of academic impact, for papers by Hiroshi Kaneko
Rankless by CCL
2026